Patents Assigned to GLOBAL BIOLIFE INC.
  • Patent number: 11311563
    Abstract: A method and composition for treating viral infections using a combination of naturally occurring compounds is provided. The method includes administering to a patient at risk of or diagnosed with a viral infection a composition including therapeutically effective amounts of a helicase ATPase inhibitor, a sialidase enzyme inhibitor, an ICAM-1 inhibitor and gallic acid which each also down regulate the immune response. The composition may further include a permeation enhancer.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: April 26, 2022
    Assignee: GLOBAL BIOLIFE INC.
    Inventor: Daryl Thompson
  • Patent number: 11246310
    Abstract: A composition and method for insect repellent is provided. The composition in one form has on a weight percentage basis 2-4% ?-pinene; 2-4% borneol; 8-10% geraniol; 28-35% linalool; 25-38% linalyl acetate; 1-4% methyl salicylate; 2-4% myrcene; 2-4% para-cymene; 4-8% phellendrene; 1-4% thymol; and 2-4% vanillin. The composition has insect repellent properties.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: February 15, 2022
    Assignee: GLOBAL BIOLIFE INC.
    Inventors: Daryl L. Thompson, Thomas A. Meyer, Nicholas A. Van Rees
  • Patent number: 11033528
    Abstract: A method and composition for treating viral infections using a combination of naturally occurring compounds is provided. The method includes administering to a patient at risk of or diagnosed with a viral infection a composition including therapeutically effective amounts of a helicase ATPase inhibitor, a sialidase enzyme inhibitor, and ICAM-1 inhibitor which each also down regulate the immune response. The composition may further include a permeation enhancer.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: June 15, 2021
    Assignee: GLOBAL BIOLIFE INC.
    Inventor: Daryl Thompson
  • Patent number: 10966954
    Abstract: A therapeutic compound has a modified phenolic compound of the general formula (I) wherein at least one of R, R1, R2, R3, and R4 is an electrophilic group chosen from halogen, aldehyde, haloalkane, alkene, butyryl, flurophenol, sulfonamide, flurophenol sulfoxide and the remaining R, R1, R2, R3, and R4 is are each independently hydrogen, a hydroxyl group, an alkoxy group, a rutinosyl group, a carboxyl group, chromone, benzopyran, a rhamnosyl group, a substituted alkoxy group or a substituted acyloxy group wherein the substituent is chosen from hydroxyl, alkoxy, aryloxy, phenyl, halogen, and amido group. The compound can be used in a therapeutic treatment of inflammatory related diseases and condition.
    Type: Grant
    Filed: May 16, 2017
    Date of Patent: April 6, 2021
    Assignee: GLOBAL BIOLIFE INC.
    Inventor: Daryl Lee Thompson
  • Patent number: 10966424
    Abstract: A composition and method for insect repellent is provided. The composition in one form has on a weight percentage basis 10-20% 2,6-dimethyl-7-octen-2-ol; 0.1-5% 2,6-octadienal, 3,7-dimethyl-; 1-10% benzyl benzoate; 0.01-2% citral; 1-10% hexamethylindanopyran; 10-40% lavender oil; 20-50% Lemon Oil Argentina; 5-15% Lime Oil Distilled Mexican; 0.01-3% limonene; 5-15% rosemary oil; and optionally 0.1-10% an insect repellent active ingredient selected from the group consisting of N,N-Diethyl-meta-toluamide (DEET), ethyl butylacetylaminopropionate and picaridin. The composition has insect repellent properties.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: April 6, 2021
    Assignee: GLOBAL BIOLIFE INC.
    Inventors: Daryl L. Thompson, Scott M. Truesdell
  • Patent number: 10383842
    Abstract: A method and composition for treating viral infections using a combination of naturally occurring compounds is provided. The method includes administering to a patient at risk of or diagnosed with a viral infection a composition including therapeutically effective amounts of a helicase ATPase inhibitor, a sialidase enzyme inhibitor, and ICAM-1 inhibitor which each also down regulate the immune response. The composition may further include a permeation enhancer.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: August 20, 2019
    Assignee: GLOBAL BIOLIFE INC.
    Inventor: Daryl Thompson
  • Patent number: 10123991
    Abstract: A therapeutic compound has a modified phenolic compound of the general formula (I) wherein at least one of R, R1, R2, R3, and R4 is an electrophilic group chosen from halogen, aldehyde, haloalkane, alkene, butyryl, flurophenol, sulfonamide, flurophenol sulfoxide and the remaining R, R1, R2, R3, and R4 is are each independently hydrogen, a hydroxyl group, an alkoxy group, a rutinosyl group, a carboxyl group, chromone, benzopyran, a rhamnosyl group, a substituted alkoxy group or a substituted acyloxy group wherein the substituent is chosen from hydroxyl, alkoxy, aryloxy, phenyl, halogen, and amido group. The compound can be used in a therapeutic treatment of inflammatory related diseases and condition.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: November 13, 2018
    Assignee: GLOBAL BIOLIFE INC.
    Inventor: Daryl Lee Thompson